Dean S. Elterman¹, Naeem Bhojani², Christopher Vannabouathong¹, Bilal Chughtai³, Kevin C. Zorn²

Canadian Journal of Urology, Vol.29, No.2, pp. 11075-11079, 2022

Abstract Introduction: This analysis reported outcomes of treating catheter-dependent urinary retention with Rezum water vapor therapy.
Materials and methods: A prospective registry was established at two high-volume Canadian centers. Patients had baseline medical and benign prostatic hyperplasia (BPH) history documented. The subgroup of patients with refractory, catheter-dependent urinary retention was analyzed. The primary outcome was the proportion of patients who were spontaneously voiding and catheter-free at 6 months.
Results: Sixteen patients (age: 68.7 years) with catheter-dependent urinary retention were treated with Rezum. Average prostate volume was 84.4 mL and 75% had median lobe. All patients had at least one… More >

Gopal Narang, Jonathan Moore, Haidar Abdul-Muhsin, Scott Cheney, Mitchell Humphreys

Canadian Journal of Urology, Vol.29, No.2, pp. 11067-11074, 2022

Abstract Introduction: Holmium laser enucleation of the prostate (HoLEP) is an effective but underutilized option for the surgical management of benign prostatic hyperplasia (BPH). With low adoption, questions arise surrounding patients access to care. It is unclear whether patients undergoing HoLEP are local or specifically seek care from afar. We looked to determine the proportion of patients who traveled out-of-state for HoLEP treatment and the impact of travel on peri and postoperative metrics.
Materials and methods: We performed a retrospective cohort study evaluating patients that underwent HoLEP at a single institution from 2007-2019. Patient demographic, perioperative data, postoperative… More >

Facundo Davaro¹, David Weinstein¹, Ryan Wong¹, Sameer Siddiqui¹, Leslie Hinyard², Zachary Hamilton¹

Canadian Journal of Urology, Vol.29, No.2, pp. 11059-11066, 2022

Abstract Introduction: Management of prostate cancer has seen an increasing predilection for active surveillance in low risk (LR) patients. We aimed to evaluate the rate of pathologic upgrading in patients with very low (VLR) or LR prostate cancer after prostatectomy.
Materials and methods: The National Cancer Database (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) Database were queried for patients diagnosed with Gleason 6 prostate cancer and prostate specific antigen (PSA) < 10 ng/mL from 2010 to 2016. All patients underwent 12-core biopsy and a subsequent prostatectomy for final pathologic staging. Our primary outcome was rate of… More >

Jessica C. Dai¹, Tara N. Morgan¹, Alaina Garbens¹, Samuel Kusin², Hersh Trivedi², Claus G. Roehrborn¹, Jeffrey C. Gahan¹

Canadian Journal of Urology, Vol.29, No.2, pp. 11052-11058, 2022

Abstract Introduction: Anticholinergic or ß-3 agonist use following robotic simple prostatectomy (RASP) is not well described. We describe rates of antispasmodic use following RASP and identify potential predictors of medication use.
Materials and methods: A retrospective review of all RASP patients from 2/2016 - 1/2020 was conducted. Patients with no preoperative International Prostate Symptom Score (IPSS) were excluded. Demographics, clinical data, and postoperative medication use were collected by electronic medical record review. Multivariable logistic regression analysis using a priori variables was performed to identify independent factors associated with antispasmodic use.
Results: A total of 255 patients underwent RASP at… More >

Kathleen Olson, Rohan Vaidya, Aqsa Khan

Canadian Journal of Urology, Vol.29, No.2, pp. 11046-11051, 2022

Abstract Introduction: Urethral diverticulum in a male is a rare entity and the literature is limited to case reports and small case series. The aim of our study is to characterize this disease in patients from three Mayo Clinic locations.
Materials and methods: Chart analysis was performed of patients across all three Mayo Clinic sites that had International Classification of Diseases (ICD) codes corresponding to urethral diverticulum or urethral diverticulectomy via CPT code. Data were available for patients that were seen from 6/1/2003 through 10/5/2018. Patients were classified by age, etiology, presenting symptomatology, location, treatment, pathology, and postoperative outcomes.
… More >

James Malone-Lee

Canadian Journal of Urology, Vol.29, No.2, pp. 11045-11045, 2022

Abstract This article has no abstract. More >

Remigio Vela Navarrete

Canadian Journal of Urology, Vol.29, No.2, pp. 11042-11044, 2022

Abstract This article has no abstract. More >

Leonard G. Gomella

Canadian Journal of Urology, Vol.29, No.2, pp. 11040-11041, 2022

Abstract This article has no abstract. More >

Niccola B. Lynch¹, Rena D. Malik²

Canadian Journal of Urology, Vol.29, No.3, pp. 11194-11197, 2022

Abstract Total pelvic exenterations (TPE) are high morbidity procedures, with up to 38% of patients experiencing a major complication after TPE surgery. We report the case of a 69-year-old woman with a sigmoid conduit-neovaginal fistula who presented with new onset continuous vaginal leakage and decreased urostomy output 3 months post-op from a TPE. We highlight the presentation, diagnosis, conservative management, and surgical management of conduit-vaginal fistulas. More >

John M. Myrga¹, Christopher J. Staniorski¹, Robert M. Turner III¹, Michelle J. Semins²

Canadian Journal of Urology, Vol.29, No.3, pp. 11190-11193, 2022

Abstract Subcapsular renal hematoma (SRH) is an infrequent complication of urologic interventions but can lead to serious consequences in patients with a solitary kidney. We present our experience with conservative management of a patient with a solitary kidney and multiple medical comorbidities who developed a SRH and subsequent renal failure after nephroureteral catheter placement. Literature on the management of this unique clinical scenario is limited. Herein, we share our experience with supportive care and temporary dialysis in a medically complex patient whose outcome is complete renal recovery. More >